Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-14

FDA Approved: VILAZODONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Teva's supplemental application for vilazodone hydrochloride, updating the drug's labeling under its existing approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vilazodone hydrochloride (vilazodone hydrochloride)

Snippet

SUPPL AP for VILAZODONE HYDROCHLORIDE (VILAZODONE HYDROCHLORIDE)